{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:28:41Z","timestamp":1793636921756,"version":"4.5.1"},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:p>This cohort study explores biliary outcomes associated with use of glucagon-like peptide-1 receptor agonists in youths aged 12 to 21 years with overweight or obesity diagnosis.<\/jats:p>","DOI":"10.1001\/jamapediatrics.2026.3918","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:30:25Z","timestamp":1788190225000},"page":"1282","source":"Crossref","is-referenced-by-count":0,"title":["Biliary Events and GLP-1 Receptor Agonist Therapy in Adolescents and Young Adults"],"prefix":"10.1001","volume":"180","author":[{"given":"Jos\u00e9lio","family":"Rodrigues de Oliveira Filho","sequence":"first","affiliation":[{"name":"Division of Pediatric Surgery, Department of Surgery, Mass General Brigham, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Papadakis","sequence":"additional","affiliation":[{"name":"Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reagan A.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer N.","family":"Shnawa","sequence":"additional","affiliation":[{"name":"Division of Pediatric Surgery, Department of Surgery, Mass General Brigham, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia L.","family":"Griggs","sequence":"additional","affiliation":[{"name":"Division of Pediatric Surgery, Department of Surgery, Mass General Brigham, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"pld260034r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.39887","article-title":"Characterizing GLP-1 receptor agonist use in preadolescent and adolescent populations.","volume":"7","author":"Miller","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"pld260034r2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","article-title":"Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials.","volume":"182","author":"He","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"24","key":"pld260034r3","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity.","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"issue":"22","key":"pld260034r4","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity.","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"pld260034r5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa2407379","article-title":"Liraglutide for children 6 to &lt;12 years of age with obesity\u2014a randomized trial.","volume":"392","author":"Fox","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"pld260034r6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ijo.2014.12","article-title":"Gallstone disease in severely obese children participating in a lifestyle intervention program: incidence and risk factors.","volume":"38","author":"Heida","year":"2014","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"pld260034r7","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1210\/jc.2018-01008","article-title":"New avenues in the regulation of gallbladder motility\u2014implications for the use of glucagon-like peptide-derived drugs.","volume":"104","author":"Gether","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"pld260034r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101242","article-title":"Incretin-based drugs and the risk of gallbladder or biliary tract diseases among patients with type 2 diabetes across categories of body mass index: a nationwide cohort study.","volume":"56","author":"Ko","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"pld260034r9","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2025.1506780","article-title":"Gallstones after bariatric surgery: mechanisms and prophylaxis.","volume":"12","author":"Chen","year":"2025","journal-title":"Front Surg"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2853456\/jamapediatrics_rodrigues_de_oliveira_filho_2026_ld_260034_1793385775.10807.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:01:03Z","timestamp":1793635263000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2853456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.3918","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11,1]]}}}